BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 36097233)

  • 1. Stereotactic body radiation therapy for metastatic lung metastases.
    Kimura T; Fujiwara T; Kameoka T; Adachi Y; Kariya S
    Jpn J Radiol; 2022 Oct; 40(10):995-1005. PubMed ID: 36097233
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stereotactic body radiation therapy in the treatment of cancer patients with oligometastatic disease: a real world study.
    Stefanovic M; Calvet G; Pérez-Montero H; Esteve A; Bujalance MV; Navarro-Martín A; Fernández MDA; González FF; Borras SM; Borbalas AL; Fernandez MN; Garau MM; Calduch AL; Edo FG
    Clin Transl Oncol; 2023 Jan; 25(1):199-206. PubMed ID: 36068449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Review of Prospective Trials Assessing the Role of Stereotactic Body Radiation Therapy for Metastasis-directed Treatment in Oligometastatic Genitourinary Cancers.
    Huynh MA; Tang C; Siva S; Berlin A; Hannan R; Warner A; Koontz B; De Meeleer G; Palma D; Ost P; Tran PT
    Eur Urol Oncol; 2023 Feb; 6(1):28-38. PubMed ID: 36283936
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stereotactic body radiotherapy (SBRT) for medically inoperable lung metastases-A pooled analysis of the German working group "stereotactic radiotherapy".
    Rieber J; Streblow J; Uhlmann L; Flentje M; Duma M; Ernst I; Blanck O; Wittig A; Boda-Heggemann J; Krempien R; Lohaus F; Klass ND; Eble MJ; Imhoff D; Kahl H; Petersen C; Gerum S; Henkenberens C; Adebahr S; Hass P; Schrade E; Wendt TG; Hildebrandt G; Andratschke N; Sterzing F; Guckenberger M
    Lung Cancer; 2016 Jul; 97():51-8. PubMed ID: 27237028
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repeat stereotactic body radiotherapy for oligometastatic disease.
    Willmann J; Adilovic S; Vlaskou Badra E; Christ SM; Ahmadsei M; Tanadini-Lang S; Mayinger M; Guckenberger M; Andratschke N
    Radiother Oncol; 2023 Jul; 184():109671. PubMed ID: 37059336
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oligometastatic Disease (OMD): The Classification and Practical Review of Prospective Trials.
    Izmailov T; Ryzhkin S; Borshchev G; Boichuk S
    Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958408
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A review of ongoing trials of stereotactic ablative radiotherapy for oligometastatic disease in the context of new consensus definitions.
    Li GJ; Arifin AJ; Al-Shafa F; Cheung P; Rodrigues GB; Palma DA; Louie AV
    Ann Palliat Med; 2021 May; 10(5):6045-6051. PubMed ID: 32787370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a Prognostic Model for Overall Survival in Patients With Extracranial Oligometastatic Disease Treated With Stereotactic Body Radiation Therapy.
    Chen H; Poon I; Atenafu EG; Badellino S; Biswas T; Dagan R; Erler D; Foote M; Redmond KJ; Ricardi U; Sahgal A; Louie AV
    Int J Radiat Oncol Biol Phys; 2022 Dec; 114(5):892-901. PubMed ID: 34890753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metastasis-directed Therapy in Prostate Cancer: Prognostic Significance of the ESTRO/EORTC Classification in Oligometastatic Bone Disease.
    Nicholls L; Chapman E; Khoo V; Suh YE; Tunariu N; Wang Y; van As N
    Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):63-69. PubMed ID: 34756755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Contemporary Update on the Role of Stereotactic Body Radiation Therapy (SBRT) for Liver Metastases in the Evolving Landscape of Oligometastatic Disease Management.
    Robin TP; Raben D; Schefter TE
    Semin Radiat Oncol; 2018 Oct; 28(4):288-294. PubMed ID: 30309639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Disease course of lung oligometastatic colorectal cancer treated with stereotactic body radiotherapy.
    Nicosia L; Cuccia F; Mazzola R; Ricchetti F; Figlia V; Giaj-Levra N; Rigo M; Tomasini D; Pasinetti N; Corradini S; Ruggieri R; Alongi F
    Strahlenther Onkol; 2020 Sep; 196(9):813-820. PubMed ID: 32399637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stereotactic radiotherapy or metastasectomy for oligometastatic esophagogastric cancer: A nationwide population-based cohort study.
    Kroese TE; Jorritsma NKN; van Laarhoven HWM; Verhoeven RHA; Mook S; Haj Mohammad N; Ruurda JP; van Rossum PSN; van Hillegersberg R
    Clin Transl Radiat Oncol; 2022 Nov; 37():109-115. PubMed ID: 36186924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oligometastatic Colorectal Cancer: A Review of Definitions and Patient Selection for Local Therapies.
    Miller ED; Hitchcock KE; Romesser PB
    J Gastrointest Cancer; 2023 Dec; 54(4):1116-1127. PubMed ID: 36652155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ablative dose stereotactic body radiation therapy for oligometastatic disease: a prospective single institution study.
    Burkon P; Kazda T; Pospisil P; Slavik M; Kominek L; Selingerova I; Blakaj DM; Prochazka T; Vrzal M; Rehak Z; Slampa P
    Neoplasma; 2019 Mar; 66(2):315-325. PubMed ID: 30509112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extracranial Stereotactic Body Radiotherapy in Oligometastatic or Oligoprogressive Breast Cancer.
    Weykamp F; König L; Seidensaal K; Forster T; Hoegen P; Akbaba S; Mende S; Welte SE; Deutsch TM; Schneeweiss A; Debus J; Hörner-Rieber J
    Front Oncol; 2020; 10():987. PubMed ID: 32676455
    [No Abstract]   [Full Text] [Related]  

  • 16. Lung Metastases Treated With Stereotactic Ablative Radiation Therapy in Oligometastatic Colorectal Cancer Patients: Outcomes and Prognostic Factors After Long-Term Follow-Up.
    Agolli L; Bracci S; Nicosia L; Valeriani M; De Sanctis V; Osti MF
    Clin Colorectal Cancer; 2017 Mar; 16(1):58-64. PubMed ID: 27522627
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Follow-up and Patterns of Recurrence of Patients With Oligometastatic NSCLC Treated With Pulmonary SBRT.
    Hörner-Rieber J; Bernhardt D; Blanck O; Duma M; Eich HT; Gerum S; Gkika E; Hass P; Henkenberens C; Herold HU; Hildebrandt G; Imhoff D; Kahl H; Janssen S; Jurianz K; Krempien R; Lautenschläger SF; Lohaus F; Mueller AC; Petersen C; Sackerer I; Scafa D; Schrade E; Uhlmann L; Wittig A; Guckenberger M
    Clin Lung Cancer; 2019 Nov; 20(6):e667-e677. PubMed ID: 31327644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stereotactic body radiotherapy (SBRT) can delay polymetastatic conversion in patients affected by liver oligometastases.
    Nicosia L; Cuccia F; Mazzola R; Figlia V; Giaj-Levra N; Ricchetti F; Rigo M; Bonù M; Corradini S; Tolia M; Alongi F
    J Cancer Res Clin Oncol; 2020 Sep; 146(9):2351-2358. PubMed ID: 32356176
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligometastasis in breast cancer-current status and treatment options from a radiation oncology perspective.
    Piroth MD; Krug D; Feyer P; Baumann R; Combs S; Duma MN; Dunst J; Fastner G; Fietkau R; Guckenberger M; Haase W; Harms W; Hehr T; Sedlmayer F; Souchon R; Strnad V; Budach W
    Strahlenther Onkol; 2022 Jul; 198(7):601-611. PubMed ID: 35527272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereotactic Body Radiotherapy for Management of Pulmonary Oligometastases in Stage IV Colorectal Cancer: A Perspective.
    Fu MX; Carvalho C; Milan-Chhatrisha B; Gadi N
    Clin Colorectal Cancer; 2023 Dec; 22(4):402-410. PubMed ID: 37748936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.